This study evaluates the efficacy of MR-HIFU ablation of breast cancer. Ten patients with
early-stage breast cancer with a maximum diameter of 3 cm will undergo MR-HIFU ablation,
followed by MRI and surgical resection to evaluate treatment effect. The main purpose of the
study is to demonstrate the feasibility of total tumor ablation with MR-HIFU. The secondary
objective is safety assessment.
Philips Sonalleve MR-HIFU Breast Tumor Therapy System
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.